Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.
- DOI
- 10.1007/s11060-024-04682-7
- Published
- 2024 Aug
- Container
- Journal of neuro-oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11060-024-04682-7,
title = {Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.},
author = {Mrugala MM and Shi W and Iwomoto F and Lukas RV and Palmer JD and Suh JH and Glas M},
year = {2024},
journal = {Journal of neuro-oncology},
doi = {10.1007/s11060-024-04682-7},
url = {https://doi.org/10.1007/s11060-024-04682-7}
}RIS
TY - JOUR TI - Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022. AU - Mrugala MM AU - Shi W AU - Iwomoto F AU - Lukas RV AU - Palmer JD AU - Suh JH AU - Glas M PY - 2024 JO - Journal of neuro-oncology DO - 10.1007/s11060-024-04682-7 UR - https://doi.org/10.1007/s11060-024-04682-7 ER -
APA
MM, M., W, S., F, I., RV, L., JD, P., JH, S., & M, G. (2024). Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.. Journal of neuro-oncology. https://doi.org/10.1007/s11060-024-04682-7
Source records
- pubmed · retrieved 2026-09-26T02:34:59.662Z
- europe-pmc · retrieved 2026-09-26T02:34:59.728Z